What is MLYS's dilution risk score?

MLYS has a latest available DilutionScore record of 41/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for MLYS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for MLYS?

DilutionWatch tracks 25 SEC filing types for MLYS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect MLYS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For MLYS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for MLYS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for MLYS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

MLYS Dilution Risk Score: 41/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

52

💰 Cash Runway

40

📊 Float Risk

25

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for MLYS.

🔔 Track MLYS — Get forecast alerts →

Market Data

Market Cap$2.60B

Shares Outstanding88.41M

Float60.37M

Cash$138.27M

Debt$100.0K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 4.0% shares (2026Q1 vs prior)

217 institutional holders · 105.75M shares

#1 Catalys Pacific, LLC 7.90M shares

#2 RA CAPITAL MANAGEMENT, L.P. 7.69M shares

#3 SAMSARA BIOCAPITAL, LLC 5.87M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest9.31M

Days to Cover15.1

% of Float15.4%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2024-02-07

xbrl XBRL CONVERTIBLE 2023-12-31

4 INSIDER TRANSACTION 2026-04-02

4 INSIDER TRANSACTION 2026-03-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual MLYS Dilution Snapshot

Mineralys Therapeutics, Inc. (MLYS) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for MLYS: 4 on 2026-04-02; 4 on 2026-04-02; 4 on 2026-03-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.